Ledger.Open graph →
SEC Form D · filed April 25, 2022

Aurion Biotech, Inc

Offering
$26.1M
Sold
$26.1M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (27)

Andrew Elbardissi · SEATTLE, WADirectorDavid Rostov · SEATTLE, WAExecJeannette Bankes · SEATTLE, WADirectorLink William · SEATTLE, WADirectorPatrick Lally · SEATTLE, WADirectorChristine Mccauley · SEATTLE, WADirectorGreg Kunst · SEATTLE, WAExec · DirectorArnaud Lacoste · SEATTLE, WAExecTom Frinzi · SEATTLE, WADirectorSwitzer Robert · Long Beach, CADirectorRich Johnson · Long Beach, CAExecJennifer Stapp · Long Beach, CAExecWhite Robert · Long Beach, CADirectorJonathan Bain · Grand Cayman, Cayman IslandsDirectorJustin Ryvicker · Whippany, NJExec · DirectorJennifer Frist · NASHVILLE, TNDirectorAri Herman · New York, NYDirectorElvin Lopez · Whippany, NJDirectorNatan Linder · Boston, MADirectorUdayan Umapathi · Boston, MADirectorConnie Wang · Austin, TXExec · DirectorRob Carlson · Frederick, MDDirectorDaniella Kranjac · Frederick, MDDirectorJon Rowley · Frederick, MDExecTimothy Kelly · Frederick, MDDirectorRobert Preti · Frederick, MDExecEric Patterson · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗